Target NRP1 therapy (Secarna)

N/A

Report date: 2024/09/13 13:57:18
NME

Base Information

Drug NameTarget NRP1 therapy (Secarna)
Drug Alias NameTarget SECN-15 therapy (Secarna)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionNeuropilin-1 modulators
TargetsNeuropilin-1
Therapy Area/IndicationsMetabolic DiseasesHeart DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSecarna Pharmaceuticals GmbH & Co KG
China Registration ClassN/A

Develop Information

Active CompaniesSecarna Pharmaceuticals GmbH & Co KG
Inactive CompaniesN/A
Active IndicationsMetabolic DiseasesHeart DiseasesNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A